MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacbts.2026.101658

Медицинская библиотека · JACC. Basic to translational science · 2026

SGLT2-Inhibitors and Molecular Signatures of Aortic Valve Remodeling in Severe Aortic Stenosis: The Valve-AS Study.

Paolisso Pasquale, Scisciola Lucia, Basilicata Manuela Giovanna, Salviati Emanuela, Belmonte Marta, Delrue Leen, Comentale Giuseppe, Policastro Pasquale, Redivo Marco, Piras Linda, Zito Francesco, Coli Marco, Mistrulli Raffaella, Joshi Rashmi, Gallinoro Emanuele, Bergamaschi Luca, Pizzi Carmine, Casselman Filip, Stockman Bernard, Aquino Giovanna, Montella Antonio Pio, Torella Michele, De Feo Marisa, Pilato Emanuele, Bartunek Jozef, Somella Eduardo Maria, Campiglia Pietro, Marfella Raffaele, Vanderheyden Marc, Paolisso Giuseppe, Barbato Emanuele, Melina Giovanni, Barbieri Michelangela

СтатьяПеревод в очереди

Аннотация

Sodium-glucose cotransporter 2 inhibitor (SGLT2i) exerts pleiotropic metabolic and anti-inflammatory effects, but its role in calcific aortic valve stenosis (CAVS) is unclear. In this multicenter prospective study, 83 patients with severe CAVS undergoing surgical aortic valve replacement were stratified by SGLT2i use. Explanted valve tissue and plasma were analyzed using transcriptomics, circulating biomarkers, and metabolomics, including MALDI-MSI. SGLT2i therapy was associated with reduced valvular expression of SGLT1/2, GLUT4, and NHE, increased PPARα, decreased PPARγ, attenuation of inflammatory signaling (lower NF-κB and IL-6), and oxidative stress response (higher SOD2). Extracellular matrix turnover and fibrocalcific remodeling enzymes (MMP-9 and MMP-12) were also reduced. Metabolomic profiling demonstrated distinct clustering, with enrichment of amino acid and redox pathways in SGLT2i users. These findings suggest that SGLT2i therapy is associated with coordinated molecular and metabolic reprogramming of the valvular microenvironment, supporting a potential disease-modifying role in CAVS.

Для цитирования: Paolisso Pasquale, Scisciola Lucia, Basilicata Manuela Giovanna, Salviati Emanuela, Belmonte Marta, Delrue Leen, Comentale Giuseppe, Policastro Pasquale, Redivo Marco, Piras Linda, Zito Francesco, Coli Marco, Mistrulli Raffaella, Joshi Rashmi, Gallinoro Emanuele, Bergamaschi Luca, Pizzi Carmine, Casselman Filip, Stockman Bernard, Aquino Giovanna, Montella Antonio Pio, Torella Michele, De Feo Marisa, Pilato Emanuele, Bartunek Jozef, Somella Eduardo Maria, Campiglia Pietro, Marfella Raffaele, Vanderheyden Marc, Paolisso Giuseppe, Barbato Emanuele, Melina Giovanni, Barbieri Michelangela. SGLT2-Inhibitors and Molecular Signatures of Aortic Valve Remodeling in Severe Aortic Stenosis: The Valve-AS Study.. JACC. Basic to translational science. 2026. DOI: 10.1016/j.jacbts.2026.101658.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.